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Cerebroglycan is a glycosylphosphatidylinositol-linked integral membrane heparan sulfate proteoglycan found exclusively
in the developing nervous system. In the rodent, cerebroglycan mRNA ®rst appears in regions containing newly generated
neurons and typically disappears 1 to several days later (Stipp et al., 1994, J. Cell Biol. 124:149±160). To gain insight into
the roles that cerebroglycan plays in the developing nervous system, monospeci®c antibodies were prepared and used to
localize cerebroglycan protein. In the rat, cerebroglycan was prominantly expressed on axon tracts throughout the devel-
oping brain and spinal cord, where it was found at times when axons are actively growing, but generally not after axons
have reached their targets. Cerebroglycan was also found on neuronal growth cones both in vivo and in vitro. Interestingly,
cerebroglycan immunoreactivity was rarely seen in or around neuronal cell bodies. Indeed, by examining the hippocampus
at a late stage in developmentÐwhen most neurons no longer express cerebroglycan but newly generated granule neurons
doÐevidence was obtained that cerebroglycan is strongly polarized to the axonal, and excluded from the somatodendritic,
compartment of neurons. The timing and pattern of cerebroglycan expression are consistent with a role for this cell-surface
heparan sulfate proteoglycan in regulating the growth or guidance of axons. q 1997 Academic Press
INTRODUCTION Lander, 1990; Lander, 1993), little is known about their
physiological functions. Molecular cloning suggests that
the core proteins of most cell surface HSPGs fall into twoHeparan sulfate proteoglycans (HSPGs) have been hy-
families: the syndecan family of transmembrane HSPGs and
pothesized to play important roles in nervous system devel-
the glypican family of glycosylphosphatidylinositol (GPI)-
opment (Lander, 1993) and have been implicated in such
anchored HSPGs. To date, four syndecan family members
diverse processes as cell±cell adhesion (Reyes et al., 1990;
have been described (Bern®eld et al., 1992). One member of
Stanley et al., 1995), cell-substratum adhesion (LeBaron et the syndecan family, syndecan-3, is highly expressed in the
al., 1988; Haugen et al., 1992), neurite outgrowth (Wang developing brain (Carey et al., 1992; Gould et al., 1995).
and Denburg, 1992), and growth factor signaling (Yayon et The glypican family is currently composed of four mam-
al., 1991; Kan et al., 1993; Aviezer and Yayon, 1994; Zion- malian proteins: glypican, cerebroglycan, OCI-5, and K-
check et al., 1995). glypican, as well as the product of the Drosophila dally
Although several distinct cell surface HSPGs are ex- gene (Lander et al., 1996). The amino acid sequences of
pressed in the developing nervous system (Herndon and these GPI-anchored HSPGs show considerable homology
throughout their length, including an invariant pattern of
14 cysteines that confers upon these molecules a compact,1 To whom correspondence should be addressed. Fax: (714) 824-
disul®de-stabilized tertiary structure. Two of these HSPGs,4709. E-mail: jkivins@UCI.edu.
cerebroglycan and glypican, have been directly isolated2 Present address: Molecular Neurobiology Laboratory, 10010 N.
from developing rat brain (Karthikeyan et al., 1992, 1994;Torrey Pines Road, Salk Institute, La Jolla, CA.
Litwack et al., 1994; Stipp et al., 1994), and it appears that3 Present address: Department of Molecular and Cell Biology,
Harvard University, 16 Divinity Ave., Cambridge, MA. these, along with syndecan-3, are the major carriers of cell
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quick-frozen in isopentane on dry ice. Twenty-micrometer cryostatsurface heparan sulfate in the developing brain. By in situ
sections of all samples were collected on Probe-On Plus slideshybridization, cerebroglycan expression is restricted to the
(Fisher) and stored at 0807C. Un®xed tissue sections were post®xeddeveloping nervous system where it is transiently expressed
by immersion in 4% paraformaldehyde in PBS for 10 min at roomin regions containing newly postmitotic neurons (Stipp et
temperature prior to storage.al., 1994). In contrast, glypican mRNA is expressed in ven-
For immunohistochemistry, sections were incubated in blocking
tricular zones in the developing rat brain and by many pro- solution (2% bovine serum albumin [BSA]; 3% goat serum; 100
jection neurons throughout development and into adult life mM Tris±Cl, pH 7.5; 150 mM NaCl; 0.3% Triton X-100). Sections
(Karthikeyan et al., 1992, 1994; Litwack et al., 1994). The were washed in TBS (100 mM Tris, pH 7.5; 150 mM NaCl) and, if
mRNAs encoding K-glypican and OCI-5 have also been de- sections were to be developed with horseradish peroxidase, treated
twice for 30 min each in 0.3% H2O2 in methanol and washed againtected at low levels in the developing and adult rodent brain
in TBS. Af®nity-puri®ed 521-2 antibody, diluted in blocking solu-(Watanabe et al., 1995), and although their expression pat-
tion, was applied overnight at room temperature at a concentrationterns have not been thoroughly characterized to date, K-
of 2.5±5 mg/ml. For immuno¯uorescence, a Cy3-conjugated goatglypican mRNA has been detected in the ventricular zone
anti-rabbit antibody (Jackson Immunoresearch) was used at a dilu-of the developing cerebral cortex (Watanabe et al., 1995).
tion of 1:100 in blocking solution as a secondary antibody. SectionsThe distribution of OCI-5 is currently unknown.
were coverslipped with a solution of ProLong antifade reagent (Mo-
To investigate the roles that HSPGs of the glypican family lecular Probes) in GelMount (Biomeda). For immunoperoxidase
play in neuronal growth and development, we have raised staining, a biotin-conjugated goat anti-rabbit antibody (Vector) di-
speci®c polyclonal antibodies to the core protein of cerebro- luted 1:300 in blocking solution was used as a secondary antibody.
glycan and used these antibodies to localize cerebroglycan Sections were washed in TBS and then incubated in ABC reagent
(Vector) diluted in 0.1 M Tris (pH 7.5). Sections were washed againduring the development of the rodent central nervous sys-
in 0.1 M Tris and developed in 50 mg/ml DAB/0.3% H2O2/0.1 Mtem. As described below, cerebroglycan is localized primar-
Tris. Sections were washed in H2O, dehydrated, cleared in xylenes,ily, if not exclusively, to the growing axons and growth
and coverslipped using Permount. In some cases, sections werecones of newly generated neurons, a result that suggests a
counterstained with either methyl green (0.1%) or bisbenzamidefunction for this HSPG in axonal growth and/or guidance.
(20 mg/ml) prior to dehydration and mounting. Nonspeci®c staining
was de®ned as staining that occurred in the absence of primary
antiserum. Sections were examined on a Zeiss Axiophot micro-
METHODS scope equipped for bright®eld, DIC, and epi¯uorescence.
Antipeptide Antibodies
Proteoglycan Isolation and Radioiodination
The peptide CRPPRPPRPPRRDGL, which corresponds to amino
Proteoglycans (PGs) were isolated from detergent extracts of neo-acids 521±535 of rat cerebroglycan (Stipp et al., 1994), was synthe-
natal rat brain membranes by sequential salt elution from DEAE-sized and puri®ed by reverse-phase HPLC (Biopolymers Lab, M.I.T.)
Sephacel (Pharmacia) essentially as described (Herndon and Lander,and coupled to keyhole limpet hemocyanin (KLH) as follows: 20
1990). For radioiodination, PGs were rebound to approximately 50mg of KLH (Pierce Chemical Co., Rockford, IL) was activated by
ml of DEAE-Spectra/Gel (Spectrum) in 3±4 volumes of 0.05 M Tris,reaction with 2 mg sulfo-SMCC (Pierce) at room temperature with
pH 8.0, containing 0.5% CHAPS overnight at 47C. The beads werestirring for 30 min. Activated KLH was puri®ed over a Sephadex
isolated, washed with 0.05 M Tris, pH 8.0, to remove detergent,G-25 column (Pharmacia) equilibrated in 0.1 M sodium phosphate
and transferred to a polypropylene tube with a minimum volume(pH 6.0). Twenty-two milligrams of peptide 521 was dissolved in
of buffer. PGs were iodinated with 5 mCi of Na125I (NEN Dupont).the same buffer and allowed to react overnight at room temperature
Iodinations were initiated with the addition of 4 ml of a 1 mg/mlwith the activated KLH. KLH-521 complexes were puri®ed over a
solution of chloramine T, allowed to proceed for 3 min at roomSephadex G-25 column. Rabbits were injected intradermally with
temperature, and terminated with the addition of 43 ml each of 102.5 mg KLH-521 in complete Freund's adjuvant and boosted twice
mM sodium metabisul®te and 10 mM KI. Beads were transferredintramuscularly with 2.5 mg KLH-521 in incomplete Freund's adju-
to a column, washed with 20 ml of 0.05 M Tris, pH 8.0; 0.5%vant. Antisera were collected and subsequently af®nity-puri®ed
CHAPS; 150 mM NaCl and eluted with 8 1 50-ml aliquots of 0.05over peptide 521 coupled to Sulfo-Link (Pierce); the resulting af®n-
M Tris, pH 8.0; 0.5% CHAPS; 750 mM NaCl. Fractions containingity-puri®ed antibody was designated 521-2. An anti-glypican anti-
the peak radioactivity were pooled and brought to 1 mg/ml BSA.body, designated 343-1 and directed against amino acids 343±360
Aliquots were ¯ash frozen on dry ice/ethanol and stored at 0807C.of rat glypican, was prepared in a similar fashion (E. D. Litwack et
Protein determinations were made prior to the addition of BSAal., in preparation).
using the amido black method essentially as described (Herndon
and Lander, 1990) with crystalline BSA as standard, except that
proteins were precipitated with 10% trichloroacetic acid (TCA).Immunohistochemistry
Embryonic Sprague±Dawley rats were removed from timed preg-
nant females and ®xed by overnight immersion in 4% paraformal- Glycosaminoglycan (GAG) Lyase Digestion,
dehyde in Ca2//Mg2/-free Dulbecco's phosphate-buffered saline SDS±PAGE, and Western Blotting
(PBS) at 47C and subsequently cryoprotected in 15% sucrose in PBS.
Date of sperm positivity was considered to be Embryonic Day 1 Digestions with heparitinase, chondroitinase ABC (Seikagaku),
or both enzymes were performed on 125I-labeled PGs as described(E1). Brains from postnatal animals were quickly removed and
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(Herndon and Lander, 1990), in the presence of 1 mM EDTA, 1 mg/ containing the full open reading frame of the cerebroglycan cDNA
(Stipp et al., 1994) into the multicloning site of the pLNCX retrovi-ml phenylmethylsulfonyl ¯uoride (PMSF), 25 mg/ml N-ethyl malei-
imide (NEM), and 1 mg/ml pepstatin A, in a volume of 30 ml. All ral expression vector (Miller and Rosman, 1989). C2 cells were
transfected with pLNCX-CBGD3* using lipofectamine (Gibco BRL)incubations were carried out at 377C except digestions with hepari-
tinase alone, which were performed at 437C to inhibit any contami- according to the instructions of the manufacturer. Conditioned me-
dium from the transfected C2 cells was used to infect C2 cellsnating chondroitinase activity. After 4±6 hr, digestions were termi-
nated by the addition of 7.5 ml 51 SDS sample buffer, heated to treated with 200 ng/ml tunicamycin and 8 mg/ml polybrene, creat-
ing stable, virus-producing cell lines.957C for 10 min, and analyzed by SDS±PAGE. For Western blotting,
neonatal brain membranes were subjected to GAG lyase digestion PC12 cells were grown in RPMI 1640 with 10% heat-inactivated
horse serum, 5% fetal calf serum, glutamine, and penicillin/strepto-in the presence of protease inhibitors, resolved by SDS±PAGE, and
electrophoretically transferred to Immobilon P. To block nonspe- mycin on Vitrogen (Celltrix)-coated plates. Cells expressing cere-
broglycan were generated by infecting PC12 cells with conditionedci®c protein binding, the membrane was incubated in TBS con-
taining 3% goat serum, 2% BSA, and 0.3% Tween 20 for 30 ±60 medium, containing 8 mg/ml polybrene, from C2 producer cell
lines. Infected PC12 cells were selected by growth in 1 mg/ml G418min, followed by incubation overnight in the same buffer con-
taining 2.5mg/ml 521-2 antibody. Incubation with enhanced chemi- and maintained as an uncloned population by growth in 0.5 mg/
ml G418; the cells were designated PC12infuCBGD3*. For immuno-luminescence reagents was performed according to the instructions
of the manufacturer (Amersham, Arlington Heights, IL). histochemistry, PC12infuCBGD3* cells were grown on laminin-
coated coverslips (20 mg/ml). Cells were rinsed once in prewarmed
RPMI and then ®xed for 10 min at room temperature in 4% para-
Immunoprecipitation formaldehyde, 5% sucrose in PBS and processed for immunohisto-
chemistry as described above using a Cy3-conjugated second anti-
Immunoprecipitations were performed from 125I-labeled PGs body (Jackson Immunoresearch) at a dilution of 1:100. Coverslips
starting with 0.51 106 TCA-precipitable cpm of material. PGs were were washed in TBS, mounted in Aquamount, and imaged on a
subjected to digestion with appropriate GAG lyases, brought to a confocal microscope (MRC-1024) using identical image acquisition
volume of 200 ml with the addition of 0.05 M Tris, pH 8.0; 0.5% parameters for both infected and parental control cell lines.
CHAPS; 150 mM NaCl (buffer C) containing EDTA and PMSF, and Embryonic Day 18 retinal neurons were cultured using timed
cleared by the addition of 30 ml of a 50 mg/ml solution of protein pregnant rats as described (Calof et al., 1994). Neurons were plated
A±Sepharose beads (Sigma) in the same buffer. After rocking for
onto merosin (Life Technologies; 40 mg/ml)-coated glass coverslips.
30±60 min at 47C, beads were pelleted by centrifugation and the
After 16±20 hr they were ®xed and processed for immuno¯uores-
supernatants transferred to fresh tubes. Antibodies were added and
cence as described above.
the tubes were incubated overnight at 47C with rocking. Immune
complexes were collected on protein A±Sepharose for several hours
at 47C by the addition of 50 ml protein A±Sepharose. Beads were
RESULTScollected by centrifugation, washed once with 1 ml buffer C, once
with buffer C containing 750 mM NaCl, and again with buffer C.
Beads were eluted with 30 ml 21 SDS sample buffer at 957C for 10 Production and Characterization of Antipeptide
min and the eluate was analyzed by SDS±PAGE. In some experi- Antibodies
ments, samples were washed before elution with 50 mM Tris, pH
A synthetic peptide corresponding to amino acids 521±8.0; 150 mM NaCl; 1.0% SDS; 1 mM EDTA, 1 mg/ml PMSF; 25 mg/
ml NEM; and 1 mg/ml pepstatin A. Identical results were obtained. 535 of the cerebroglycan coding sequence was synthesized,
coupled to KLH, and used to produce an antiserum in rab-
bits. The resulting serum, 521-2, was af®nity-puri®ed
Growth Cone Particle Preparation against the same peptide. To con®rm the speci®city of the
af®nity-puri®ed antibody, 40 mg of neonatal rat brain mem-Growth cone particles (GCPs) were prepared from Postnatal Day
0 (P0) rat brains as described (Greenberger and Pfenninger, 1986; brane protein was digested with either heparitinase or chon-
Skene et al., 1986; Simkowitz et al., 1989). Brie¯y, brains (including droitinase or a mixture of both GAG lyases and subjected
olfactory bulbs) were removed into ice-cold PBS, dissected free of to Western blot analysis (Fig. 1). A single 52-kDa band was
meninges, and homogenized in 10 volumes GCP buffer (10 mM seen following heparitinase digestion, but not in untreated
TES, pH 7.4; 1 mM MgCl2; 0.32 M sucrose; PMSF (1 mg/ml); pep- samples or samples subjected to chondroitinase digestion
statin A (1 mg/ml); and N-ethyl maleiimide (2.5 mg/ml). Homoge- alone. In samples not treated with heparitinase (lanes C
nates were clari®ed by centrifugation at 5000g for 15 min at 47C
and U), a broad high-molecular-weight smear can faintly beand gently layered onto discontinuous sucrose gradients consisting
seen, indicative of an undigested heparan sulfate proteogly-of 0.83 M, 1.0 M, and 2.0 M sucrose steps in GCP buffer. Gradients
can. Digestion with both chondroitinase and heparitinasewere centrifuged at 242,000g in a swinging bucket rotor at 47C for
did not alter the mobility of the immunoreactive band fur-40 min. GCPs were isolated from a band of white material forming
at the ®rst sucrose interface. ther than was observed with heparitinase digestion alone,
consistent with previous observations that cerebroglycan
bears only heparan sulfate GAG chains (Herndon and
Primary Cell Culture and Establishment of C2 and Lander, 1990). The poor immunostaining of undigested
PC12 Cell Lines Expressing Cerebroglycan cerebroglycan (lanes C and U) is most likely due to the poor
binding of GAG-bearing PGs to protein blotting membranesA cerebroglycan expression vector, pLNCX-CBGD3*, was con-
structed by subcloning the 1835-bp EagI/NarI restriction fragment (Rapraeger et al., 1985) and not to an inability of the antise-
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(Fig. 3). Highest levels of immunoreactivity were seen in the
cerebral cortex, anterior commissure, fornix, optic chiasm,
deep layers of the cerebellum, superior and inferior colliculi,
and midbrain and brain stem.
Close examination of these and other sections suggests that
cerebroglycan is predominantly, if not exclusively, associated
with developing axon tracts. For example, in saggital sections
through the neocortex at P0 (Fig. 4A), high levels of cerebrogly-
can immunoreactivity are seen in the intermediate zone and
in ®bers that extend from the intermediate zone through the
cortical plate toward the pial surface (arrows). This pattern
of immunoreactivity corresponds to the pathway by which
thalamic axons enter the cortex. These axons grow through
FIG. 1. Western blot of cerebroglycan in Postnatal Day 0 rat brain the intermediate zone parallel to the ventricular surface before
membranes. 18 mg protein was loaded in each lane of a nonreducing turning or sending collaterals that grow upward toward their
SDS gel, which was subsequently transferred to Immobilon P,
termination zones in the cortical plate (Miller et al., 1993).probed with the 521-2 antibody, and processed for enhanced chemi-
Although the same pathway is followed by descending corticalluminescence. Lanes are marked as follows: U, untreated; H, hepar-
axons, at least some of the cerebroglycan immunoreactivityitinase treated; C, chondroitinase treated; CH, heparitinase- and
along this pathway is likely to be present on thalamocorticalchondroitinase-treated. A single band of molecular weight 52 kDa
axons, since cerebroglycan mRNA is present at high levels inis observed only following heparitinase digestion; chondroitinase
treatment does not alter its migration further. In samples not the thalamus at similar stages of development (Stipp et al.,
treated with heparitinase (C and U), a broad high-molecular-weight 1994). Within the cortex, cerebroglycan-immunoreactivity is
smear can faintly be seen, indicative of an undigested heparan sul- also seen in the marginal zone, a layer which consists primarily
fate proteoglycan. of intracortical axons. The ventricular zone, which contains
proliferating neural precursors, but very few axons, is devoid
of immunoreactivity. In control sections incubated in the ab-
sence of the primary antibody, no immunoreactivity is ob-
rum to recognize the intact cerebroglycan molecule, since served (Fig. 4B).
521-2 readily immunoprecipitates intact cerebroglycan Cerebroglycan immunoreactivity can also be seen on ®-
from a complex mixture of proteoglycans (see below). ber bundles coursing within the super®cial layers of the
To prove the speci®city of the antibody, PC12 cells, superior colliculus at P0; these presumably correspond to
which do not express any endogenous cerebroglycan (M. E. the axons of retinal ganglion cells invading the stratum
Herndon, C. S. Stipp, and A. D. Lander, unpublished obser- opticum (Fig. 4C), although afferents arising from the cere-
vations), were infected with a replication-defective retrovi- bral cortex also project to this region. In intermediate layers
rus engineered to direct expression of a full-length cerebro- of the superior colliculus, ®bers cut in cross section stain
glycan cDNA. Infected cells stained strongly with the 521- prominently. Based on their position and orientation, these
2 antibody (Fig. 2A) in a distinctly punctate pattern similar ®bers are likely to be tectobulbar axons (Fig. 4C) which run
to that seen for other cell-surface GPI-anchored proteins as tightly fasciculated bundles perpendicular to the ingrow-
(Sargiacomo et al., 1993; Lisanti et al., 1994). In contrast, the ing optic axons (Kroger and Walter, 1991). Cerebroglycan
uninfected parental PC12 cell line showed only background immunoreactivity can also be seen on presumptive cortico-
levels of immunoreactivity (Fig. 2B). tectal ®bers in the deep layers of the superior colliculus
(Fig. 4C). These are likely to correspond to inputs from corti-
cal visual areas, but could also represent descending projec-Cerebroglycan Expression in the Developing
tions from the superior colliculus to the reticular formation,Rat Brain
pontine nucleii, inferior olive, or spinal cord (Altman and
Bayer, 1981b). However, since those descending ®bers ariseIn situ hybridization has suggested that cerebroglycan
mRNA is restricted to the developing nervous system and, from cell bodies dispersed throughout all collicular layers,
and little cerebroglycan mRNA has been observed in thefurthermore, that the onset of cerebroglycan gene expres-
sion in different parts of the nervous system correlates with superior colliculus at this age (Fig. 6I of Stipp et al., 1994),
the cerebroglycan-immunoreactive ®bers most likely corre-the terminal mitoses of neurons (Stipp et al., 1994). In ex-
tracts of whole rat brain, cerebroglycan protein expression spond to corticotectal afferents.
Cerebroglycan immunoreactivity is also seen in the hip-peaks near the day of birth (Herndon and Lander, 1990). To
determine the localization of cerebroglycan in the devel- pocampal formation of the neonatal rat brain. In the coronal
section shown in Fig. 4D, immunoreactivity is seen withinoping nervous system, we immunostained cryostat sections
of rat brain at several developmental ages, concentrating on the stratum radiatum, where both intrahippocampal com-
missural axons as well as the axons of the Schaffer collateralP0. In parasaggital sections of P0 rat heads, cerebroglycan
immunoreactivity was restricted to the nervous system pathway from the hippocampal pyramidal neurons project.
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FIG. 2. Immunostaining of PC12 cells transfected with a cerebroglycan transgene. PC12 and PC12infuCBGD3* cells were grown on
laminin-coated coverslips and stained for cerebroglycan. Cerebroglycan immunoreactivity was visualized using a Cy3-conjugated second
antibody. Coverslips were imaged on a MRC-1024 confocal microscope using identical image acquisition parameters for both PC12infu-
CBGD3* (A) and the parental PC12 cell line (B), demonstrating that cerebroglycan immunoreactivity is only seen in the transfected cell
line. Bar, 15 mm.
Weak immunoreactivity is also seen in the mossy ®ber ity can also be seen in a cell layer beneath the external
granule layer, corresponding to the developing Purkinje celllayer, the site of axons that arise from granule neurons
within the dentate gyrus and project toward area CA3. In layer. Immunoreactivity in this layer appears stronger in
dorsal than in ventral cerebellum, a difference that corre-the same section, prominent cerebroglycan immunoreactiv-
ity can be seen within several other axon pathways, includ- lates with the maturational gradient of Purkinje cell devel-
opment. In dorsal regions of the rat cerebellum, Purkinjeing the optic tract, the ®mbria of the fornix, the intermedi-
ate zone of the cerebral cortex, the corpus callosum, and cells are still migrating into the Purkinje cell layer as late
as Embryonic Day 22, but have completed their migrationsthe internal capsule (not shown). Other major axon tracts
that stain strongly for cerebroglycan include the anterior several days earlier in the more posterior and ventral cere-
bellum (Altman and Bayer, 1985b). Thus, in the cerebellumcommissure (Fig. 3), the posterior commissure (Fig. 4E), and
spinal commissural axons (see below, Fig. 5). as in the inferior colliculus, the strongest immunoreactivity
is associated with the least mature postmitotic neurons.
In the olfactory bulb (Fig. 4H), weak cerebroglycan stainingThe Timing of Cerebroglycan Expression can be seen in the olfactory nerve layer, which contains the
Correlates with Stages of Cell Migration intermingled axons of olfactory receptor neurons at variousand Early Axon Growth stages of maturity (Shipley and Ennis, 1996). Intense cerebro-
glycan immunoreactivity is seen, however, in the rostral mi-In many regions of the developing brain, regional varia-
gratory stream of newly born interneurons which originate intions in cerebroglycan immunoreactivity correlate with dif-
the anterior subventricular zone and subsequently migrate intoferences in the developmental stages of neurons. For exam-
the olfactory bulb. Immunoreactivity is also apparent on theple, in the inferior colliculus the highest levels of cerebro-
presumptive axons of mitral cells in the internal plexiformglycan immunoreactivity are seen in the most caudal and
layer. In older animals, at P21, speci®c cerebroglycan immuno-ventral regions (Fig. 4F), where the most recently postmi-
reactivity is still visible throughout the granular layer of thetotic neurons are located (Altman and Bayer, 1981a). These
bulb, consistent with observations that granular neurons con-are also the regions that hybridize most strongly for cerebro-
tinue to be generated throughout the life of the rat (Kaplanglycan mRNA at this stage (Stipp et al., 1994). In the P0
and Hinds, 1977), as well as on axons within the lateral olfac-cerebellum (Fig. 4G), the heaviest labeling is seen in the
tory tract (not shown) which presumably correspond to thedeep layers in a pattern that correlates with the migratory
axons of mitral cells (see Discussion).paths taken by neurons settling into the deep cerebellar
nucleii (Altman and Bayer, 1985a). Weaker immunoreactiv- In the spinal cord, where neurogenesis is completed earlier
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FIG. 3. Immunohistochemical localization of cerebroglycan in a Postnatal Day 0 rat head. A frozen section through a P0 rat head was
immunostained for cerebroglycan and visualized with HRP and DAB and counterstained with methyl green. Immunoreactivity is seen in
many regions of the CNS including the cortex (ctx), optic nerve and tract (o), anterior commissure (ac), fornix (f), cerebellum (cb), midbrain
(mb), and inferior (ic) and superior (sc) colliculi. No immunoreactivity is seen outside of the nervous system. Bar, 1 mm.
than in most parts of the central nervous system (Altman lateral, and ventral funiculi. Immunoreactivity observed in the
dorsal funiculus correlates well with the growth of supraseg-and Bayer, 1984), cerebroglycan mRNA appears before E12 and
disappears by E19 (Stipp et al., 1994). Figure 5 shows the local- mental ascending collaterals of spinal sensory neurons within
the developing propriospinal tract (Mirnics and Koerber, 1995).ization of cerebroglycan immunoreactivity in the E14 and E18
spinal cord. At E14 (Fig. 5A), intense staining is seen on the Many of these ascending ®bers originating in the caudalmost
regions of the spinal cord do not reach their targets in theaxons of spinal commissural neurons approaching and crossing
the ¯oorplate, on motor axons leaving the ventral cord in the hindbrain until P0. Immunoreactivity seen in the lateral and
ventral funiculi is most likely due to descending motor axonsventral motor roots, and on axons within both the central
and the peripheral roots of sensory neurons of the dorsal root of the reticulospinal and rubrospinal tracts. Axons of each of
these tracts have begun to penetrate the spinal cord by E16ganglia, especially as they enter the spinal cord in the dorsal
root entry zones. Immunoreactivity is not seen in the ventricu- and have reached mid- to lower thoracic levels by E18 (Lakke
and Marani, 1991; Kudo et al., 1993).lar zone of the spinal cord nor in the notocord. Thus, cerebro-
glycan is expressed on every major axon tract in the E14 spinal
cord. A similar pattern of staining, albeit less intense, was also Cerebroglycan Is Polarized to Axons in the Hilarobserved in the E12 spinal cord.
Region of the Hippocampal Dentate GyrusIn contrast, by E18, the pattern of cerebroglycan immunore-
activity has changed dramatically (Fig. 5B), and no longer in- Although cerebroglycan immunoreactivity is especially
intense in developing ®ber tracts, it does not necessarilycludes the axon pathways of primary motor neurons which
have largely reached their targets by this stage (Altman and follow that cerebroglycan is expressed more highly on axons
than on other parts of the neuron. Because the density ofBayer, 1984). Instead, immunoreactivity is seen in the dorsal,
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FIG. 5. Cerebroglycan expression in the developing rat spinal cord. Embryonic rats were immersion ®xed in paraformaldehyde, cryopro-
tected in sucrose, sectioned in the coronal plane at 20 mm on a cryostat, and processed for cerebroglycan immunohistochemistry as
described and photographed with bright®eld optics. (A) At E14, cerebroglycan immunoreactivity is observed on all major axonal tracts
present within the developing spinal cord, including spinal commissural axons (c), sensory axons of the dorsal root ganglia (drg)Ðwhich
are especially prominent at the dorsal root entry zones (drez), and motor axons (m) exiting the cord within the ventral roots. (B) At E18,
cerebroglycan immunoreactivity is greatly reduced throughout the spinal cord except in the dorsal (df), lateral (lf), and ventral (vf) funiculi
where axons of the corticospinal tract are actively growing. Bar, 100 mm.
plasma membrane in axon bundles is much higher than in To circumvent these problems, we turned to the P21 hip-
pocampus. This stage is long after the generation of mostregions of neuronal cell bodies, immunostaining for pro-
teins that are evenly distributed on neuronal plasma mem- neurons and, accordingly, cerebroglycan expression in the
brain as a whole is extremely low. In the hippocampus,branes can often appear much stronger on ®ber tracts than
around cell bodies (Morris and Grosveld, 1989). Levels of however, production of new granule neurons continues in
the dentate gyrus throughout life, albeit at a low levelstaining of dendritic ®elds should, in principle, be more
comparable with that of axon bundles. However, because (Kaplan and Hinds, 1977; Bayer, 1980; Altman and Bayer,
1990a,b), so one might expect to see small numbers of hip-cerebroglycan is ubiquitously expressed in the developing
nervous system, it is dif®cult to assess levels of dendritic pocampal granule neurons expressing cerebroglycan even in
adult animals. Conveniently, the axons and dendrites ofstaining, since it is dif®cult to ®nd ®elds of dendrites that
are not intermixed with potentially cerebroglycan-positive dentate granule neurons extend from a compact layer of
neuronal cell bodies and grow in opposite directions, withaxons.
FIG. 4. Immunohistochemical localization of cerebroglycan within the developing rat brain. Frozen sections of P0 rat brain were cut at
20 mm in the saggital plane except in D which is a coronal section. In each panel, rostral is to the left. All sections were counterstained
with methyl green and photographed under bright®eld illumination except E which was photographed using differential interference
contrast microscopy. (A) The intermediate zone (iz) of the developing neocortex stains strongly for cerebroglycan as does the marginal
zone (mz). Staining can also be seen on ®bers extending through the cortical plate (cp). No staining is seen in the ventricular zone (vz).
(B) A section through neocortex similar to A except that the primary antibody was omitted. (C) In the superior colliculus, cerebroglycan
immunoreactivity is seen on optic axons within the stratum opticum (so), on tectobulbar (tb) axons seen in cross section in central tectal
regions, and on corticotectal afferents (ct) in the deep tectal layers. (D) In the hippocampus, weak cerebroglycan immunoreactivity is seen
in the mossy ®ber layer in the hilar region of the dentate gyrus (dg), extending throughout the stratum radiatum (sr). Strong immunoreactiv-
ity is visible in the ®mbria of the fornix (ff), as well as in the optic tract (ot) in the dorsal thalamus. (E) Large fascicles of axons within
the posterior commissure stain strongly for cerebroglycan. (F) Within the caudal inferior colliculus, cerebroglycan immunoreactivity is
widespread, absent only from the ventricular zone (vz). (G) In the cerebellum, strong immunoreactivity is seen throughout the deep
cerebellar layers. Cerebroglycan is also seen in the Purkinje cell layer (pcl), where immunoreactivity is seen in dorsal, but not ventral
regions. (H) In the olfactory bulb, the strongest cerebroglycan immunoreactivity is seen in the inner plexiform layer (ipl), presumably
associated with mitral cell axons, as well as on presumptive granule neurons (gr) within the rostral migratory stream (rms). Weak
immunoreactivity is also seen within the olfactory nerve (onl) and glomerular layers (gl). Bar in all panels, 100 mm except D (bar, 200 mm)
and E (bar, 25 mm).
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a single axon heading basally into the hilar region (to join
other mossy ®bers) and a single dendrite heading apically
(Bayer, 1980; Gaarskjaer, 1986). Thus, at P21 it should be
possible to individually examine cerebroglycan expression
on well-separated axons, cell bodies, and dendrites of small
numbers of granule neurons, without interfering immuno-
staining from any other cell type.
As shown in Fig. 6, this was indeed the case. In sections of
the P21 hippocampus, small numbers of thin cerebroglycan-
immunoreactive ®bers were scattered throughout the hilar
region; these ®bers had the appearance of individual axons.
In contrast, little if any cerebroglycan immunoreactivity
was detected among the granule cell bodies nor among the
layer containing their dendrites. These data demonstrate
that, at least for some neurons, cerebroglycan is restricted
to the axonal compartment and suggest that this polarized
expression pattern may be a general feature of cerebroglycan
expression.
Cerebroglycan Is Expressed on Neuronal
Growth Cones
The strong localization of cerebroglycan to the axons of
newly generated neurons raises the possibility that it could
function on axonal growth cones. To address whether cere-
broglycan is expressed on growth cones in vitro and in vivo,
E18 retinal neurons were cultured on merosin-coated glass
coverslips for 20 hr and immunostained for cerebroglycan.
As can be seen in Fig. 7, strong cerebroglycan immunoreac-
tivity was observed on growing neurites, including the
growth cones. Heavy staining was seen along the leading
edge of veil-rich regions (Fig. 7A), as well as along ®lopodia,
where highly punctate staining (Figs. 7B and 7C), consistent
with clustering of cerebroglycan in the membrane, was typi-
cally observed.
To determine if cerebroglycan is also a prominent compo-
nent of growth cones in vivo, total proteoglycans were puri-
®ed from freshly isolated growth cone particles and radioio-
dinated, and their core proteins were analyzed by SDS±
PAGE following digestion with speci®c GAG lyases (Fig.
8A). Three major HSPGs were seen in these preparations,
with apparent core protein molecular weights of approxi-
mately 135, 60, and 54 kDa, corresponding to syndecan 3,
glypican, and cerebroglycan (formerly known as HSPGs M7,
M12, and M13, respectively; Herndon and Lander, 1990).
Identical results were obtained in ®ve independent prepara-
tions. The identi®cation of the 60- and 54-kDa species as
FIG. 6. Cerebroglycan expression in the hilar region of the Post-glypican and cerebroglycan, respectively, was based on the
natal Day 21 rat hippocampus. Saggital sections of fresh-frozenability of anti-glypican and anti-cerebroglycan antisera to
P21 rat brain were cut at 12 mm on a cryostat, post®xed, andspeci®cally immunoprecipitate these molecules (Fig. 8B).
stained with the 521-2 antibody. Antibody binding was visual-The identi®cation of HSPG M7 as syndecan 3 was made
ized using a Cy3-conjugated anti-rabbit second antibody, and
on the basis of an anti-syndecan 3 antiserum (generously the section was counterstained with bisbenzamide to allow vi-
provided by Dr. M. Bern®eld) to speci®cally immunoprecip- sualization of nucleii. (A) Schematic of the cellular anatomy of
itate the 135-kDa species (not shown). Although the relative the dentate gyrus. (B) Nuclei of granule neurons in the dentate
proportions of cerebroglycan, glypican, and syndecan-3 in gyrus labeled with bisbenzamide. (C) Cerebroglycan immunore-
activity demonstrated on mossy ®bers by immuno¯uorescence.growth cone particles are similar to those in whole-brain
Bar, 40 mm.membranes (cf. Herndon and Lander, 1990), PGs as a whole
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FIG. 7. Cerebroglycan expression on retinal growth cones in vitro. Retinal neurons from E18 rats were cultured overnight on merosin-
coated glass coverslips. After ®xation, they were immunostained for cerebroglycan, visualized using a Cy3-conjugated second antibody,
and photographed at 631 under rhodamine ¯uorescence. Three separate examples of neurites bearing growth cones are shown in A, B,
and C. The cell bodies from which these neurites extended were also immunoreactive (not shown). Bar, 15 mm.
were enriched in the growth cone fraction. Speci®cally, in only transiently expressed by growing axons is the lateral
olfactory tract, which primarily consists of axons of thegrowth cones of neonatal rat brain, PGs constituted be-
mitral cells of the olfactory bulb, but also contains ®berstween 1.21 and 1.69% of total protein (1.43 { 0.24%, n 
that originate in the raphe nuclei and locus coeruleus and3), whereas in whole-brain membranes they were approxi-
innervate the olfactory bulb (Shipley and Ennis, 1996).mately three times less abundant (0.45% of total protein, n
Cerebroglycan immunoreactivity was detected in the lat- 2).
eral olfactory tract as late as P21 (unpublished observations),
despite the fact that mitral cells are born between E14 and
E16 (Bayer et al., 1993) and raphe and locus coeruleus neu-DISCUSSION
rons are born by E16 and E14, respectively (Bayer et al.,
1993). Other than this, the only evidence of cerebroglycan
To investigate the roles of cell surface HSPGs in neural expression at P21 was associated with regions of very late
development, we generated speci®c antibodies against neurogenesis (dentate granule neurons of the hippocampus
cerebroglycan, a GPI-anchored HSPG expressed speci®cally [Fig. 6]; granule neurons of the olfactory bulb [not shown]),
within the developing nervous system. The antibodies are or regions where small numbers of axons had not yet ®n-
directed against an epitope near the C-terminus of the ma- ished growing (e.g., the internal capsule, which contains
ture polypeptide and recognize both the core protein and some very late-developing axons of the corticospinal tract
the intact HSPG (Figs. 1, 2, and 8). Immunostaining of the [not shown]).
developing rat nervous system indicates that cerebroglycan In at least one cell type, the hippocampal granule neuron,
is highly localized to developing axon tracts and growth expression of cerebroglycan is speci®cally polarized to the
cones. Furthermore, these data indicate that cerebroglycan axonal compartment, as no dendritic or cell-body staining
is predominantly, if not exclusively, a product of neurons could be detected (Fig. 6). This could re¯ect either preferen-
(rather than glial cells), a result that in situ hybridization tial sorting or preferential stabilization of the cerebroglycan
data had suggested (Stipp et al., 1994). molecule. In several types of cells, GPI±anchors have been
As long as they were examined at stages when axons are shown to target proteins to speci®c cellular domains, in-
actively growing, all axon tracts appeared to be immunore- cluding the axonal compartment of hippocampal pyramidal
active for cerebroglycan, suggesting that cerebroglycan may neurons in vitro (Dotti and Simons, 1990). Indeed axonin-
be a general marker expressed by immature neurons. In 1/TAG-1 is another example of a GPI-anchored glycoprotein
most cases, axon tracts became cerebroglycan negative that appears to be preferentially associated with axons
within several days after the ®nal mitosis of their neurons (Dodd et al., 1988). Nevertheless, it cannot be that GPI
of origin (cf. Fig. 5), usually around the time that axons anchorage targets cerebroglycan or other proteins to axons,
arrived at their targets. For instance, the axons of spinal since the GPI-anchored glycoprotein Thy-1 is actually ex-
sensory neurons, which reach their central targets between cluded from growing axons in vivo (Xue et al., 1991). It will
E16 and E18 (Mirnics and Koerber, 1995b), stained strongly be interesting to determine whether particular structural
for cerebroglycan at E14, but had largely lost cerebroglycan features in the core protein and/or glycosaminoglycan
immunoreactivity by E18. chains of cerebroglycan play a direct role in controlling the
unique localization of this proteoglycan.An apparent exception to the rule that cerebroglycan is
Copyright q 1997 by Academic Press. All rights of reproduction in any form reserved.
AID DB 8532 / 6x21$$$$61 03-26-97 12:18:03 dba
330 Ivins et al.
on axons from early stages of axon elongation to the time
that synaptic contacts are initially made. This corresponds
to the time when most of the navigational decisions of ax-
ons are being made. That cerebroglycan may play a role in
these decisions is supported by the fact that this HSPG is
highly localized to axons and, importantly, is expressed on
growth cones, the organelles that are directly responsible
for axonal responses to guidance cues. Interestingly, it ap-
pears that not just cerebroglycan, but all three of the major
HSPGs of the developing brainÐcerebroglycan, glypican,
and syndecan-3Ðare prominent components of growth
cones (cf. Fig. 8). In addition, immunoreactivity for both
glypican (Karthikeyan et al., 1994) and syndecan-3 (Gould et
al., 1995) has been seen on axon tracts. These observations
suggest that cell surface HSPGs in general may play an
important role in the responses of growth cones to their
environment.
Currently, the most accepted model of how cell surface
heparan sulfate proteoglycans function is that they act as
coreceptors for a variety of secreted and cell-surface ligands.
These include growth factors, such as the ®broblast growth
FIG. 8. Cerebroglycan expression in neonatal rat brain growth factors, that require an interaction with heparin or heparan
cone particles. (A) Total proteoglycans were isolated from P0 rat sulfate in order to bind to and initiate signaling from their
brain growth cone particles by ion-exchange chromatography, ra- receptors (Rapraeger et al., 1991; Yayon et al., 1991). They
dioiodinated, digested with speci®c GAG lyases, and analyzed by also include extracellular matrix proteins, such as ®bronec-
SDS±PAGE on a 7.5% nonreducing gel. Lanes are untreated (U), tins, laminins, and thrombospondins (Woods and Couch-
chondroitinase ABC treated (C), heparitinase treated (H), and di-
man, 1992). It is noteworthy that many of the molecules ingested with both chondroitinase ABC and heparitinase (CH). Three
these categories affect the behavior of growth cones anddistinct HSPGs are resolved following digestion with heparitinase,
may serve as axon guidance cues in vitro and in vivo (Gomezbut not with chondroitinase. The core protein of syndecan 3 has
and Letourneau, 1994; Kuhn et al., 1995; McFarlane et al.,an apparent MW of approximately 135 kDa, glypican has an appar-
ent MW of 60 kDa, and cerebroglycan has an apparent MW of 1995). Whether cerebroglycan, or any other HSPG, is in-
approximately 54 kDa. (B) Immunoprecipitation of glypican and volved in growth cone responses to these molecules remains
cerebroglycan from radioiodinated growth cone proteoglycans. Im- to be seen. However, it has been shown in some systems
munoprecipitations were performed with anti-glypican (antibody that removal of heparan sulfate (Wang and Denburg, 1992),
343-1) and anti-cerebroglycan (antibody 521-2) antisera as described or removal of GPI-anchored molecules (Chang et al., 1992),
under Methods, following digestion with GAG lyases as indicated. can interfere with growth cone guidance in vivo.
Immune complexes were eluted with hot SDS sample buffer and
To date, the most de®nitive data on the function of GPI-resolved by SDS±PAGE on a 7.5% nonreducing gel.
anchored HSPGs in the nervous system comes from the
study of mutant alleles of the Drosophila dally (division
abnormally delayed) gene, which encodes a proteoglycan
In a few cases, cerebroglycan staining in the P0 rat brain of the glypican family that is approximately 45% similar
was not obviously associated with axon tracts: In the cere-
to each of the known glypican family members, including
bellum, the strongest immunoreactivity was associated
cerebroglycan (Lander et al., 1996; Nakato et al., 1995). Inwith regions where newly postmitotic neurons (deep cere-
¯ies homozygous for hypomorphic dally alleles, the laminabellar neurons, Purkinje cells) were completing cell migra-
precursor cells, which give rise to synaptic target neuronstion (Fig. 4G). Similarly, in the P0 olfactory bulb, strong
for photoreceptor axons, show a delayed entry into mitosisimmunoreactivity was associated with the rostral migra-
in the ®rst of two stereotypic cell divisions. The second celltory stream, the ®nal stage of the migratory pathway for
division, which is triggered by an intercellular signal fromseveral types of olfactory interneurons (Fig. 4H). It is possi-
the photoreceptor axons as they arrive in the target region,ble that the immunoreactivity seen in these locations repre-
does not occur. Although the mechanism underlying thissents staining of early axonal processes that are extended
phenotype has yet to be elucidated, the results are consis-by cells as they migrate. More likely, in some neurons,
tent with a defect in a growth factor signaling pathway. Itcerebroglycan may initially be expressed diffusely, before
will be interesting to determine whether the dally proteinbecoming polarized to axons.
acts as a coreceptor for any known Drosophila growth fac-
Potential Functions of Cerebroglycan tors and, if so, whether vertebrate homologs of those growth
factors also employ members of the glypican family as core-The data presented here indicate that, in most if not all
of the central nervous system, cerebroglycan is expressed ceptors.
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